©The Author(s) 2026.
World J Gastroenterol. Jan 7, 2026; 32(1): 112496
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.112496
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.112496
Table 5 Various types of clinical genetic testing
| Classification | Type | Purpose |
| Mutation origin | Germline testing | Detects inherited mutations; used for familial risk, carrier status, and predisposition |
| Somatic testing | Identifies acquired mutations in specific tissues (e.g., tumors); guides cancer therapy | |
| Mosaicism testing | Identify mosaicism in FAP, IBD | |
| Clinical purpose | Diagnostic testing | Confirms or rules out a specific genetic disorder in symptomatic individuals |
| Prognostic testing | Predicts disease course, severity, or likelihood of complications | |
| Predictive/screening | Identifies asymptomatic individuals at risk of developing a genetic disorder | |
| Carrier testing | Identifies individuals who carry one copy of a gene mutation (relevant for recessive conditions) | |
| Pharmacogenetic testing | Assesses genetic variants affecting drug metabolism and response | |
| Somatic/tumor profiling | Detects actionable mutations in cancer cells to guide targeted therapy and prognosis | |
| Newborn screening | Early identification of treatable genetic disorders in neonates |
- Citation: Kumar A, Sarangi Y, Kaw P. Gene, genetics and genetic medicines in gastroenterology: Current status and its future. World J Gastroenterol 2026; 32(1): 112496
- URL: https://www.wjgnet.com/1007-9327/full/v32/i1/112496.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i1.112496